BioSpace News Archive

Here are some criteria used to identify the highest-quality life sciences candidates and some insight on how you can pick the cream of the crop for your organization.

The Project Management Institute announced its Most Influential Projects list. The list has some of the best biotechnology innovations that took place in recent years.

Sensyne Health plc, the British clinical AI technology company, announced it has entered into a formal research agreement with the UK MHRA to contribute to the development of methods to validate software algorithms used in digital health.

Successful review of HEMOBLAST Bellows’ performance and safety profile as well as Biom’up’s Quality Management System by the Australian Therapeutic Goods Administration (TGA)

ProBioGen AG and Ceva Santé Animale announce the signature of an exclusive license agreement for the manufacture of vectorised poultry vaccines using ProBioGen’s proprietary AGE1.CR® technology.

MRI evaluation suggests slowing of cartilage damage and potential chondroprotection in osteoarthritis of the knee

Dr. Dennise Broderick, President and Managing Director of global speciality pharmaceutical company, Galen, was the first member to participate in Northern Ireland Chamber of Commerce and Industry’s CEO Spotlight Series.

Global Blood Therapeutics, Inc., announced that on October 1, 2019, the compensation committee of GBT’s board of directors granted 12 new employees options to purchase an aggregate of 24,600 shares of the company’s common stock with a per share exercise price of $46.99 and restricted stock units for an aggregate of 57,050 shares of the company’s common stock.

Haselmeier and Stevanato Group announced an exclusive agreement to license the Axis-D pen-injector technology and intellectual property for Development, Manufacturing and Supply of the Axis-D pen-injector in the Therapeutic Area of Diabetes Care.

Single-use TPE tubing is up to 2.5 times longer lasting over extended production in peristaltic applications